Plus: The Biden administration had a plan for the next pandemic. It's fizzling out.
Hey — for a special STAT+ discount, use the code LABORDAY to get 25% your first year of our premium membership. Don't miss out. |
|
|
 UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice
On paper, it looked like control of ProHealth's offices would remain in the hands of physicians, even after UnitedHealth bought the practice. In reality, the primary care network is a shell of its former self — with doctors and patients alike leaving in droves. Read more. By Lizzy Lawrence, Casey Ross, Bob Herman, and Tara Bannow |
|
-jpg.jpeg?width=1252&height=704&upscale=true&name=Antiviral_NYC_Karen-Dias-19-2048x1152%20(1)-jpg.jpeg) Karen Dias for STAT
Exclusive: Biden administration's $3.2 billion antiviral pandemic plan is fizzling out The Antiviral Program for Pandemics aimed to protect Americans from the mistakes of the Covid-19 outbreak. But funding is slated to run out on April 30 with little to show for it. What went wrong? Read more. By Jason Mast
-jpg.jpeg?width=1252&height=704&upscale=true&name=Dexcom-Stelo_Sensor_Up-Close-1600x900%20(1)-jpg.jpeg) Dexcom
Continuous glucose monitoring for the masses is here. Are we ready for it? Over the past 25 years, continuous glucose monitors have changed the shape of diabetes care. Now they're about to become dramatically more accessible — depending on how clinicians and consumers decide to use them. Read more. By Lizzy Lawrence More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments